Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Conference News AHA 2019

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

Todd Neale

November 16, 2019

News Daily News

CTO PCI: Lower Success, More Complications vs Other Complex PCI

Yael L. Maxwell

November 13, 2019

News Conference News TCT 2019

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Michael O'Riordan

October 03, 2019

Presentation TCT 2019

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

Presenter: Carlo Briguori

September 29, 2019

CIN Prevention II: Clinical Trials Summary of Completed and Ongoing Studies

Presentation TCT 2019

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Presenter: Somjot Brar

September 28, 2019

Presentation TCT 2019

Your Cath Lab Needs a CIN Prevention Protocol: Here It Is!

Presenter: Hitinder Gurm

September 28, 2019

Presentation TCT 2019

CIN Prevention II: IV Fluids

Presenter: Carlo Briguori

September 28, 2019

CIN Prevention III: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presentation TCT 2019

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presenter: Ziad Ali

September 28, 2019

Presentation TCT 2019

CIN Risk Prediction and Outcomes

Presenter: Sripal Bangalore

September 28, 2019

Presentation TCT 2019

Contrast-Induced Nephropathy: Does It Exist and Does It Matter?

Presenter: Richard Solomon

September 28, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

Video

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

September 29, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Carlo Brigouri About REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

September 26, 2019

Advertisement

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

CTO PCI: Lower Success, More Complications vs Other Complex PCI

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Your Cath Lab Needs a CIN Prevention Protocol: Here It Is!

CIN Prevention II: IV Fluids

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

CIN Risk Prediction and Outcomes

Contrast-Induced Nephropathy: Does It Exist and Does It Matter?

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

Dr. C. Michael Gibson Talks With Dr. Carlo Brigouri About REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content